Skip to content

Russia's Diabetes Burden: Naumov Proposes Funds for Drugs to Save Lives

Naumov's proposal could provide life-saving drugs to 110,000 patients. Sugar tax revenue might fund this change to the 'Fight against Diabetes' project.

In this image we can see a doll wearing a sugar free diet coke tag.
In this image we can see a doll wearing a sugar free diet coke tag.

Russia's Diabetes Burden: Naumov Proposes Funds for Drugs to Save Lives

The financial burden of type 2 diabetes in Russia is staggering, with state spending exceeding 700 billion rubles annually. A significant portion, 80%, of these costs stem from temporary disability, permanent disability, and premature mortality. Deputy Stanislav Naumov has proposed changes to the federal project 'Fight against Diabetes' to address this issue.

Naumov's proposal aims to introduce additional funds to reduce mortality rates, delay disability, and ease the strain on the healthcare system. However, the specific organization or institution managing these funds remains unclear.

One of the key changes Naumov suggests is the purchase of cardioprotective and nephroprotective drugs for type 2 diabetes patients. These drugs can help prevent or slow down complications like heart failure and chronic kidney disease, which are major causes of death in these patients. Elvira Gustova, a leading diabetes expert, has emphasized the urgent need for such funding.

The excise tax on sugar-sweetened beverages, introduced in July 2023, has generated substantial revenue. In 2024, it brought in 18.773 billion rubles at a rate of 7 rubles per liter, with projections estimating 25.9 billion rubles in 2025 at an increased rate of 10 rubles per liter. These funds could potentially be redirected to support Naumov's proposal.

With new funds, approximately 110,000 patients who currently do not receive medication under the benefits could be provided with necessary drugs.

The proposed changes to the federal project 'Fight against Diabetes' could significantly improve the lives of type 2 diabetes patients in Russia. By providing essential drugs and reducing complications, the project aims to decrease mortality rates, delay disability, and alleviate pressure on the healthcare system. The successful implementation of these changes depends on the allocation and management of additional funds.

Read also:

Latest